Create Medic (5187) Q3 2024 earnings summary

Executive summary

• Net sales for the third quarter ended September 2024 were ¥9,512 million, up 3.8% year-over-year.

• Operating profit decreased by 14.9% to ¥521 million compared to the same quarter last year.

• Ordinary profit declined 16.4% to ¥545 million year-over-year.

• Profit attributable to owners of parent dropped sharply by 98.0% to ¥9 million.

• Comprehensive income fell 57.0% to ¥600 million.

Financial highlights

• Basic earnings per share for the quarter were ¥1.06, down from ¥83.85 in the prior year.

• Total assets as of September 2024 were ¥18,825 million, up from ¥15,019 million at December 2023.

• Net assets increased to ¥19,258 million from ¥14,944 million at the previous fiscal year-end.

• Capital adequacy ratio improved to 79.8% from 77.6% at December 2023.

• Net assets per share rose to ¥1,742.18 from ¥1,641.59.

Outlook and guidance

• Full-year net sales forecast for December 2024 is ¥13,032 million, representing a 3.5% increase year-over-year.

• Operating profit is projected at ¥868–900 million, up 8.1% at the upper end.

• Ordinary profit forecast is ¥900 million, up 3.1% year-over-year.

• Profit attributable to owners of parent is forecast at ¥967 million, with basic EPS of ¥106.22.

• Annual dividend forecast is ¥39.00 per share, including a ¥2.00 commemorative dividend.